Use of Phénobarbitaland High Doses of 1-(2-Chloroethyl)-3-cyclohexyl-1- nitrosourea in the Treatment of Brain Tumor-bearing Mice1

It has been shown that the nitrosoureas are substrates for hepatic microsomal enzymes in vitro and that phénobarbital(PB) administered in multiple doses prior to nitrosourea administration significantly reduces the activity of the nitrosoureas in murine brain tumor models. In the present study, the effect of PB on 1-(2-chloroethyl)-3cyclohexy 1-1-nitrosourea (CCNU) was assessed by determining the CCNU dose which would result in the long-term survival of 50% of the treated mice, and the CCNU dose which would result in the toxic death of 50% of the treated mice, with or without PB pretreatment in C56BL/6J mice. The therapeutic index, the CCNU dose which would result in the long-term survival of 50% of the treated mice, per the CCNU dose which would result in the toxic death of 50% of the treated mice, without PB pretreat ment was 2.1 ; the therapeutic index of CCNU after PB pretreat ment was 1.7. There is no significant difference between the therapeutic indices. Thus, the reduction in the tumoricidal activity of CCNU after PB pretreatment was restored by increasing the dose of CCNU without a significant change in its lethal toxicity.